The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Immune Globulin Subcutaneous Market Research Report 2025
Synopsis
Immune globulin subcutaneous (for injection under the skin) is used to treat primary immunodeficiency
The global Immune Globulin Subcutaneous market was valued at US$ 1864 million in 2023 and is anticipated to reach US$ 2786.8 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
North American market for Immune Globulin Subcutaneous is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immune Globulin Subcutaneous is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Immune Globulin Subcutaneous include Takeda and CSL etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immune Globulin Subcutaneous, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Globulin Subcutaneous.
Report Scope
The Immune Globulin Subcutaneous market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immune Globulin Subcutaneous market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immune Globulin Subcutaneous manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
CSL
Segment by Type
2g
4g
10g
Other
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Immune Globulin Subcutaneous manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Immune Globulin Subcutaneous in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Immune globulin subcutaneous (for injection under the skin) is used to treat primary immunodeficiency
The global Immune Globulin Subcutaneous market was valued at US$ 1864 million in 2023 and is anticipated to reach US$ 2786.8 million by 2030, witnessing a CAGR of 5.8% during the forecast period 2024-2030.
North American market for Immune Globulin Subcutaneous is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Immune Globulin Subcutaneous is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Immune Globulin Subcutaneous include Takeda and CSL etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Immune Globulin Subcutaneous, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immune Globulin Subcutaneous.
Report Scope
The Immune Globulin Subcutaneous market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Immune Globulin Subcutaneous market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Immune Globulin Subcutaneous manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Takeda
CSL
Segment by Type
2g
4g
10g
Other
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Consumption by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Immune Globulin Subcutaneous manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Immune Globulin Subcutaneous in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Immune Globulin Subcutaneous Market Overview
1.1 Product Overview and Scope of Immune Globulin Subcutaneous
1.2 Immune Globulin Subcutaneous Segment by Type
1.2.1 Global Immune Globulin Subcutaneous Market Value Comparison by Type (2024-2030)
1.2.2 2g
1.2.3 4g
1.2.4 10g
1.2.5 Other
1.3 Immune Globulin Subcutaneous Segment by Application
1.3.1 Global Immune Globulin Subcutaneous Market Value by Application: (2024-2030)
1.3.2 Immunodeficiency
1.3.3 Autoimmune Disease
1.3.4 Acute Infection
1.4 Global Immune Globulin Subcutaneous Market Size Estimates and Forecasts
1.4.1 Global Immune Globulin Subcutaneous Revenue 2019-2030
1.4.2 Global Immune Globulin Subcutaneous Sales 2019-2030
1.4.3 Global Immune Globulin Subcutaneous Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Immune Globulin Subcutaneous Market Competition by Manufacturers
2.1 Global Immune Globulin Subcutaneous Sales Market Share by Manufacturers (2019-2024)
2.2 Global Immune Globulin Subcutaneous Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Immune Globulin Subcutaneous Average Price by Manufacturers (2019-2024)
2.4 Global Immune Globulin Subcutaneous Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Immune Globulin Subcutaneous, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Immune Globulin Subcutaneous, Product Type & Application
2.7 Immune Globulin Subcutaneous Market Competitive Situation and Trends
2.7.1 Immune Globulin Subcutaneous Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Immune Globulin Subcutaneous Players Market Share by Revenue
2.7.3 Global Immune Globulin Subcutaneous Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Immune Globulin Subcutaneous Retrospective Market Scenario by Region
3.1 Global Immune Globulin Subcutaneous Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Immune Globulin Subcutaneous Global Immune Globulin Subcutaneous Sales by Region: 2019-2030
3.2.1 Global Immune Globulin Subcutaneous Sales by Region: 2019-2024
3.2.2 Global Immune Globulin Subcutaneous Sales by Region: 2025-2030
3.3 Global Immune Globulin Subcutaneous Global Immune Globulin Subcutaneous Revenue by Region: 2019-2030
3.3.1 Global Immune Globulin Subcutaneous Revenue by Region: 2019-2024
3.3.2 Global Immune Globulin Subcutaneous Revenue by Region: 2025-2030
3.4 North America Immune Globulin Subcutaneous Market Facts & Figures by Country
3.4.1 North America Immune Globulin Subcutaneous Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Immune Globulin Subcutaneous Sales by Country (2019-2030)
3.4.3 North America Immune Globulin Subcutaneous Revenue by Country (2019-2030)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Immune Globulin Subcutaneous Market Facts & Figures by Country
3.5.1 Europe Immune Globulin Subcutaneous Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Immune Globulin Subcutaneous Sales by Country (2019-2030)
3.5.3 Europe Immune Globulin Subcutaneous Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immune Globulin Subcutaneous Market Facts & Figures by Country
3.6.1 Asia Pacific Immune Globulin Subcutaneous Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Immune Globulin Subcutaneous Sales by Country (2019-2030)
3.6.3 Asia Pacific Immune Globulin Subcutaneous Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Immune Globulin Subcutaneous Market Facts & Figures by Country
3.7.1 Latin America Immune Globulin Subcutaneous Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Immune Globulin Subcutaneous Sales by Country (2019-2030)
3.7.3 Latin America Immune Globulin Subcutaneous Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Immune Globulin Subcutaneous Market Facts & Figures by Country
3.8.1 Middle East and Africa Immune Globulin Subcutaneous Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Immune Globulin Subcutaneous Sales by Country (2019-2030)
3.8.3 Middle East and Africa Immune Globulin Subcutaneous Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Immune Globulin Subcutaneous Sales by Type (2019-2030)
4.1.1 Global Immune Globulin Subcutaneous Sales by Type (2019-2024)
4.1.2 Global Immune Globulin Subcutaneous Sales by Type (2025-2030)
4.1.3 Global Immune Globulin Subcutaneous Sales Market Share by Type (2019-2030)
4.2 Global Immune Globulin Subcutaneous Revenue by Type (2019-2030)
4.2.1 Global Immune Globulin Subcutaneous Revenue by Type (2019-2024)
4.2.2 Global Immune Globulin Subcutaneous Revenue by Type (2025-2030)
4.2.3 Global Immune Globulin Subcutaneous Revenue Market Share by Type (2019-2030)
4.3 Global Immune Globulin Subcutaneous Price by Type (2019-2030)
5 Segment by Application
5.1 Global Immune Globulin Subcutaneous Sales by Application (2019-2030)
5.1.1 Global Immune Globulin Subcutaneous Sales by Application (2019-2024)
5.1.2 Global Immune Globulin Subcutaneous Sales by Application (2025-2030)
5.1.3 Global Immune Globulin Subcutaneous Sales Market Share by Application (2019-2030)
5.2 Global Immune Globulin Subcutaneous Revenue by Application (2019-2030)
5.2.1 Global Immune Globulin Subcutaneous Revenue by Application (2019-2024)
5.2.2 Global Immune Globulin Subcutaneous Revenue by Application (2025-2030)
5.2.3 Global Immune Globulin Subcutaneous Revenue Market Share by Application (2019-2030)
5.3 Global Immune Globulin Subcutaneous Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Immune Globulin Subcutaneous Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Takeda Immune Globulin Subcutaneous Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Immune Globulin Subcutaneous Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Immune Globulin Subcutaneous Product Portfolio
6.2.5 CSL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immune Globulin Subcutaneous Industry Chain Analysis
7.2 Immune Globulin Subcutaneous Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immune Globulin Subcutaneous Production Mode & Process
7.4 Immune Globulin Subcutaneous Sales and Marketing
7.4.1 Immune Globulin Subcutaneous Sales Channels
7.4.2 Immune Globulin Subcutaneous Distributors
7.5 Immune Globulin Subcutaneous Customers
8 Immune Globulin Subcutaneous Market Dynamics
8.1 Immune Globulin Subcutaneous Industry Trends
8.2 Immune Globulin Subcutaneous Market Drivers
8.3 Immune Globulin Subcutaneous Market Challenges
8.4 Immune Globulin Subcutaneous Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
